MAPT and Parkinson disease: Notably, Roberto et al. demonstrated that reduced levels of MAPT-AS1 and the presence of the MAPT H1 haplotype may combine to cause high tau-IRES activity and increase the risk of PD by disrupting tau protein homeostasis (Simone et al., 2021).